Sarepta.com Website Review

We are Sarepta Thera*eutics: a biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare neuromuscular diseases. Our primary focus is on rapidly advancing Duchenne muscular dystrophy (DMD) therapies that are designed to treat To get to the heart of DMD, it is critical for gene therapy to be delivered to skeletal and cardiac muscle. Our goal is to develop therapies to treat 100% of individuals with this devastating disease. Our commitment to the patients and families impacted by Duchenne muscular dystrophy extends beyond treatment. We are proud to offer SareptAs*ist™, a patient support program for those seeking information on therapy. Our unique RNA-based technology has the potential to advance treatments in numerous areas of high unmet need. We are continuing to advance our clinical programs for Duchenne muscular dystrophy. We're looking for people who exhibit teamwork, excellence, innovation, drive, compas*ion, and resilience. If you thrive in an environment where you can make a real difference in people's lives and where you're challenged to be the best that you can be, we encourage you to We're looking for people who exhibit teamwork, excellence, innovation, drive, compas*ion, and resilience. If you thrive in an environment where you can make a real difference in people's lives and where you're challenged to be the best that you can be, we encourage you to We seek collaborations with leaders in industry, government, and academia to make meaningful advances in medicine. Our proprietary and highly versatile RNA-based technologies form the foundation of our partnering strategy. Wednesday, January 2nd 2019Sarepta Thera*eutics Enters into Long-term Strategic Relationship with Aldevron for GMP-grade Plasmid in Support